Adam Spitz, an endocrinologist, and Georgina Farrow, a clinical pharmacist, to unpack the science, success stories, safety concerns, and future outlook for GLP-1 medications like Ozempic and Mounjaro for people with T1D
Studies examine GLP-1s potential role in: Results may vary
This drug belongs to a larger class of drugs, known as glucagon-like peptide-1 (GLP-1) receptor agonists, which was originally introduced for the treatment of type 2 diabetes
Once that stability is achieved, other metabolic peptides can be introduced to rebuild the foundation. By supporting lean muscle mass, boosting metabolic rate, and enhancing mitochondrial health, these peptides help ensure that the weight loss is primarily from fat and is sustainable for the long term
Daily handling matters too